Clinical Trials Browser

Multiple Myeloma, Neoplasms, Plasma Cell

Fallopian Tube Neoplasms, Ovarian Neoplasms

Multiple Myeloma

Prostatic Neoplasms

Multiple Myeloma, Recurrence

Multiple Myeloma

Multiple Myeloma

Multiple Myeloma

Multiple Myeloma

Multiple Myeloma, Recurrence

Multiple Myeloma

Multiple Myeloma, Recurrence

Multiple Myeloma

Prostate Cancer Metastatic

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell

Immunoglobulin Light-chain Amyloidosis, Paraproteinemias

Multiple Myeloma

Carcinoma, Non-Small-Cell Lung

Multiple Myeloma, Recurrence

Multiple Myeloma

Multiple Myeloma

Multiple Myeloma

Multiple Myeloma

Multiple Myeloma, Recurrence

Immunoglobulin Light-chain Amyloidosis, Paraproteinemias

Multiple Myeloma

Multiple Myeloma

Multiple Myeloma

Multiple Myeloma

Nausea, Vomiting

Multiple Myeloma, Recurrence

Multiple Myeloma

Multiple Myeloma

Multiple Myeloma

Multiple Myeloma

Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)

Multiple Myeloma

Carcinoma, Lung Neoplasms

Multiple Myeloma, Plasmacytoma

Multiple Myeloma

Multiple Myeloma

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

Multiple Myeloma

Multiple Myeloma, Neoplasms, Recurrence

Multiple Myeloma

Multiple Myeloma

Multiple Myeloma

Multiple Myeloma

Multiple Myeloma

Clinical Trials

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

TroFuse-022

MagnetisMM-6

MK-5684-004

A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

CARTITUDE-4

CARTITUDE-5

MajesTEC-3

A Study of Daratumumab

MonumenTAL-3

MajesTEC-7

MajesTEC-9

A Study Comparing Daratumumab, VELCADE (Bortezomib), Lenalidomide, and Dexamethasone (D-VRd) With VELCADE, Lenalidomide, and Dexamethasone (VRd) in Participants With Untreated Multiple Myeloma and for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy

OMAHA-003

OLYMPIA-4

A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIa AL Amyloidosis (CARES)

EXCALIBER-RRMM

MK-2870-009

SUCCESSOR-2

DREAMM-3

MAGNETISMM-5

iMMagine-3

A Study of GR1803 Injection Versus Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Participants With Relapsed or Refractory Multiple Myeloma

SUCCESSOR-1

A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIb AL Amyloidosis (CARES)

CERVINO

MonumenTAL-6

DURGA-4

LINKER-MM3

APF530 or Aloxi (Palonosetron Hydrochloride) Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer

A Study Comparing QLS32015 Monotherapy Versus Pomalidomide, Dexamethasone (Pd) or Selinexor, Dexamethasone (Sd) in Participants With Relapsed or Refractory Multiple Myeloma

IKEMA

A Study to Evaluate the Safety and Efficacy of SCTC21C in Combination With Bortezomib, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

DREAMM-10

Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma

A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis

A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia

Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Participants With Previously Untreated Multiple Myeloma

VITAL

Addition of Daratumumab to Combination of Bortezomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma

A Study of Combination of Daratumumab and Velcade (Bortezomib) Melphalan-Prednisone (DVMP) Compared to Velcade Melphalan-Prednisone (VMP) in Participants With Previously Untreated Multiple Myeloma

FUMANBA-03

KEYNOTE-921

A Clinical Study Comparing SG301 Plus Pomalidomide and Dexamethasone to Placebo Plus Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma Patients

A Study Designed to Evaluate the Safety and Efficacy of Venetoclax Plus Dexamethasone (VenDex) Compared With Pomalidomide Plus Dexamethasone (PomDex) in Participants With t(11;14)-Positive Relapsed or Refractory Multiple Myeloma.

DREAMM 8

CANDOR

DREAMM 7

A Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma

DREAMM 7